000590.SZ
古汉医药
SZSE · Healthcare · C 制造业 · CN
CNY 9.05
+0.00%Year over year
Reported trailing growth
- Revenue
- +3.9%
- EBITDA
- —
- EBIT
- +75.8%
- EPS
- +69.2%
- Free cash flow
- +127.3%
- Operating cash flow
- +905.8%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -1.2%
- EBITDA
- +85.7%
- EBIT
- +69.7%
- Net income
- +59.7%
- EPS
- +59.7%
- Free cash flow
- -34.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026